Abstract：【Objective】To compare the effects of four schemes for treating cesarean scar pregnancy (CSP) and the time after treatment for human chorionic gonadotropin β (β-HCG) to drop to normal level in each scheme.【Methods】A total of 130 patients with CSP were enrolled in the study. The patients were randomly divided into group A (n=32), group B (n=30), group C (n=35) and group D (n=33) by random number table method, according to patient's own will. Patients in group A were treated with methotrexate alone, patients in group B were treated with methotrexate combined with uterus curettage, patients in group C were treated with uterine artery embolization combined with methotrexate and uterus curettage, and patients in group D were treated with hysteroscopic operation. The state of operation was compared among group B, group C and group D. The recovery indexes were compared among the four groups.【Results】The vaginal bleeding time, blood β-HCG dropping to normal time, and the time of lesion disappearing in group A were [ (29.55±5.20) d, (44.01±7.23) d, (50.21±6.34) d], respectively, which were significantly longer than those in group B, group C or group D (P<0.05). The intraoperative blood loss, length of hospitalization, vaginal bleeding time and time for blood β-HCG to drop to normal in group B were [ (152.74±58.59) ml, (12.33±3.72) d, (26.18±4.08) d, (31.14±6.14) d], respectively, which were significantly more or longer than those in group C or group D (P<0.05).【Conclusion】All four schemes are effective in the treatment of CSP. Uterine artery embolization combined with hysteroscopic surgery has advantages of a small amount of bleeding, complete debridement and quick recovery, however, it requires equipment and techniques. The most reasonable treatment plan should be chosen according to the actual condition of patients.
吕燕,韩倩. 四种方案治疗子宫切口瘢痕妊娠的疗效比较[J]. 医学临床研究, 2018, 35(4): 693-695,699.
LV Yan, HAN Qian. Efficacy Comparison of Four Schemes for Treatment of Cesarean Scar Pregnancy. JOURNAL OF CLINICAL RESEARCH, 2018, 35(4): 693-695,699.
2018, Vol. 35 
